Background In patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), the frequent provocation of ventricular tachycardia during exercise, the sensitivity toward catecholamines, and the response toward antiarrhythmic drug regimen with antiadrenergic properties suggest an involvement of the sympathetic nervous system in arrhythmogenesis.
Background In patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), the frequent provocation of ventricular tachycardia during exercise, the sensitivity toward catecholamines, and the response toward antiarrhythmic drug regimen with antiadrenergic properties suggest an involvement of the sympathetic nervous system in arrhythmogenesis.
Methods and Results To analyze the presence, extent, and location of impaired myocardial sympathetic innervation in ARVC, 1"I-meta-iodobenzylguanidine (`PI-MIBG) scintigraphy was performed in 48 patients with ARVC. For comparison, 9 patients with idiopathic ventricular tachycardia and a control group of 7 patients without heart disease were investigated. In patients with ARVC, the clinical sustained (n=25; 52%) or nonsustained (n=23; 48%) ventricular tachycardia originated in the right ventricular outflow tract in 38 patients (79%), whereas in the remaining 10 patients (21%), the site of origin was the apical (n=5) or inferior (n=5) right ventricle. In 33 patients (69%), nonsustained or sustained ventricular tachycardia was provocable by exercise (n=28 of 48; 58%) and/or by isoproterenol infusion (n= 16 of 37; 43%), whereas programmed ventricular stimulation induced sustained or nonsustained ventricular tachycardia in 16 patients each (33% each). With`I MIBG scintigraphy, the right ventricle was not visible in any patient. No areas of intense 11I-MIBG uptake ("hot spots") were observed. All patients of the control group and 7 of 9 patients (78%) with idiopathic ventricular tachycardia showed a uniform tracer uptake in the left ventricle. In contrast, only 8 of 48 ARVC patients (17%) showed a homogeneous distribution of lnI-MIBG uptake, whereas 40 patients (83%) demonstrated regional reductions or defects of tracer uptake. In 3 of 48 patients (6%), the defect area was < 15%; in 21 patients (44%), it was 15% to 30%; and in 16 patients (33%), it was >30% of the polar map area of the left ventricle (mean, 23±15%; range, 0% to 57%). In 38 of 40 n young patients with ventricular tachycardia, arrhythmogenic right ventricular cardiomyopathy (ARVC) is regarded as a common underlying heart disease in the absence of coronary artery disease, ARVC has been discussed by different authors9A12and is suggested by the frequent occurrence of ventricular tachyarrhythmias during exercise, mental stress, or catecholamine provocation, which appears to trigger the arrhythmia. High efficacy rates of antiarrhythmic drug regimen including antiadrenergic agents further support an involvement of the adrenergic system in the arrhythmogenesis in ARVC. However, up to now, there has been no verification of abnormal sympathetic innervation by cardiac imaging.
1231-meta-iodobenzylguanidine (1231-MIBG) scintigraphy has recently evolved as a noninvasive method for the in vivo evaluation of the sympathetic activity by measuring postganglionic presynaptic noradrenergic uptake.14-17 Different patterns of abnormal 1231-MIBG uptake indicating abnormalities of the cardiac sympathetic activity have been demonstrated after myocardial infarction,18-21 in dilative22-24 and hypertrophic25-27 cardiomyopathy, after cardiac transplantation,22,28 and in patients with the idiopathic long QT syndrome. 29 The purpose of this study was to analyze the presence, extent, and location of impaired myocardial sympathetic innervation using 1231-MIBG, single (Fig 7) . A comparison of patients with ARVC and idiopathic ventricular tachycardia showed a clear trend toward reduced 'BI-MIBG uptake in the basal posteroseptal segments of the polar map (P<.01) in the ARVC group. However, because of the rigorous criteria of significance applied in this study (P<.002), the difference did not reach statistical significance (Fig 6) .
20`TI Myocardial SPECT
Stress/redistribution 201T1 myocardial SPECT did not demonstrate perfusion defects in any of the 48 patients with ARVC (Table 3 ). However, in 10 patients (21%), the stress images demonstrated a moderate reduction of tracer uptake that showed a complete redistribution in the rest images in 6 of them. In 8 of the 10 patients (80%) with regionally reduced 201T1 uptake in the stress images, exercise-induced frequent extrasystoles and ventricular runs were documented during and/or after exercise immediately before and/or during the acquisition of the stress images. In contrast, of 38 patients with normal 2T1 SPECT, only 3 patients (8%) had frequent arrhythmias at the time of 201T1 study. In images, a reinvestigation at rest using '9mTc-MIBI was performed 2 days later with a normal result. At that time, no arrhythmias were present before or during the investigation.
ARVC versus CONTROL Ant Sept
Reduced 20`T1 uptake was located in septal (n-3), posteroseptal (n=2), or anterior segments (n=5), the latter also involving septal (n-2), apical (n-2), lateral (n=-), or posterior (n=2) segments of the polar map. (Table 3) .
ARVC versus IDIOPATHIC VT

Discussion
General Considerations
The major clinical manifestation of ARVC is ventricular arrhythmia, which may range from frequent premature ventricular complexes and ventricular runs to nonsustained or sustained ventricular tachycardia, whereas primary ventricular fibrillation appears to be rare. Patients present with arrhythmia-related symptoms ranging from palpitations and dizziness to syncope and sudden cardiac arrest. 13 origin, diameter, and course, and there was no correlation between the location and extent of sympathetic dysinnervation and the territory or the degree of left ventricular supply by a specific coronary artery.
Hypoperfusion Hypothesis
Myocardial hypoperfusion causes reduced tracer uptake, which could result in false-positive results of '23I-MIBG scintigraphy. In our patients, however, this mechanism appears to be very unlikely because none of our patients had a history of myocardial infarction or symptoms indicating myocardial ischemia, and none of our patients had coronary artery disease (excluded by angiography) or perfusion abnormalities in areas of reduced 123I-MIBG uptake (excluded by 20'T1 SPECT scintigraphy).
In patients in whom a localized reduction of 20'Tl uptake was observed, the location did not correlate with that of reduced 1231-MIBG uptake. In contrast to patients with significant myocardial ischemia resulting from coronary artery disease, these areas were not clearly demarcated but had a scattered pattern. A localized reduction of 20'T1 uptake has also been reported in patients with left bundle branch block not related to coronary artery disease.6970 Regionally delayed depolarization with asynchronous contraction and subsequent regional impairment of relaxation with prolonged compression of coronary arteries was postulated as the underlying mechanism.69,70 Interestingly, 8 of our 10 patients with regionally reduced 20'T1 uptake presented with frequent or repetitive ventricular arrhythmias of left bundle branch block morphology during and/or after exercise and therefore immediately before and/or during the time of stress image acquisition. In contrast, such arrhythmias were present at the time of image acquisition in only 3 of 38 patients with a normal T1 scan. Therefore, a mechanism similar to that postulated in patients with left bundle branch block can be discussed.
Hyperinnervation Hypothesis
Localized sympathetic hyperinnervation of the heart may result in areas of intense '23I-MIBG uptake (hot spots). This was reported in early reports of cases with idiopathic ventricular tachycardia2958 but has not been confirmed in recent studies.20,59-62 In our study groups with ARVC and idiopathic ventricular tachycardia, no areas of intense tracer uptake were observed.
Increased cardiac sympathetic activity with augmented catecholamine turnover may result in rapid 1231-MIBG clearance, leading to reduced tracer activity some hours after injection. This has been discussed in studies analyzing patients with hypertrophic25,2671 and dilative cardiomyopathy. 22, 23, 71 In our study, assessment of global and regional kinetics of '23I-MIBG by serial scintigraphic imaging was not available. However, in five patients with ARVC, we obtained additional l1I-MIBG scans 30 minutes after injection, showing no evidence of regionally enhanced tracer uptake. In our patients, therefore, rapid tracer washout resulting from localized hyperinnervation appears to be an unlikely mechanism of regionally reduced '23I-MIBG uptake.
Competitive inhibition of intraneuronal '23I-MIBG uptake by high levels of circulating plasma catecholamines has been discussed as a potential mechanism for the diffuse reduction of cardiac '23I-MIBG uptake and the acceleration of tracer washout in patients with pheochromocytoma.16 In contrast, despite elevated plasma catecholamine levels, no competitive inhibition of 'nI-MIBG uptake was found in patients with dilative cardiomyopathy or congestive heart failure. 22-24'64 Despite the convincing evidence of sympathetic dysinnervation in patients with ARVC, there is no proof from the present study that there is a causal relation between the abnormalities of sympathetic innervation observed in '231-MIBG imaging and the occurrence of ventricular tachycardia because sympathetic dysinnervation was also demonstrated in patients without provocation of ventricular tachycardia by exercise or isoproterenol infusion. Because the response to fl-blockers was not prospectively studied, no firm conclusions can be drawn on the value of 1231-MIBG scintigraphy as a predictor of response toward drug regimen, including /3-blockade. However, the majority of patients were effectively treated with either f-blockers or sotalol, and more than half of the nonresponders toward these agents proved refractory toward all other drugs tested.
The precise mechanism of reduced myocardial 1231.
MIBG uptake remains to be elucidated. The available data, however, are in favor of sympathetic denervation as the underlying mechanism. Enhanced catecholamine turnover with rapid tracer washout cannot be fully excluded because kinetic studies of global and regional 1231-MIBG uptake were not available in our patients. However, additional '23I-MIBG images, which were acquired in five patients with ARVC 30 minutes after injection of the tracer, gave no evidence of a regionally enhanced 121-MIBG uptake indicating localized hyperinnervation. Plasma catecholamine levels from the systemic circulation and from the coronary sinus also were not available. However, competitive inhibition of '23I-MIBG uptake in the intraneuronal pool due to by guest on April 18, 2017 http://circ.ahajournals.org/ Downloaded from elevated catecholamine levels is very unlikely because of the localized and nondiffuse pattern of sympathetic dysinnervation. Furthermore, previous studies showed that plasma or urine catecholamine concentrations were not elevated in patients with catecholamine-sensitive ventricular tachycardia. 72, 73 No firm conclusions, however, can be drawn concerning the relation of systemic and/or cardiac plasma catecholamine concentrations and the mechanism or characteristics of ventricular tachycardia.
Clinical Implications
The present study provides convincing evidence that in the majority of patients with ARVC, significant abnormalities of the sympathetic innervation of the heart exist and can be demonstrated by '"I-MIBG imaging. A typical finding of circumscribed reduction in 1"I-MIBG uptake located in the basal posteroseptal left ventricle may have implications for the early noninvasive diagnosis of ARVC in its classic or concealed manifestation. The capability of 13I-MIBG scintigraphy to depict these dysinnervations appears to depend on a location of structural right ventricular abnormalities adjacent to the interventricular septum because the right ventricle itself cannot be displayed by 13I-MIBG imaging.
Because patients with ventricular tachycardia associated with an imbalance of the sympathetic tone appear to benefit from antiarrhythmic therapy including p-blockade,9,13,52,80,88 the detection of sympathetic dysinnervation by 13I-MIBG imaging might also have therapeutic implications. The finding of drug response toward either 3-blockers or sotalol in the majority of our patients with ARVC further supports this hypothesis.
Prospective large-scale studies are necessary to further evaluate the clinical value of 1231-MIBG scintigraphy as a diagnostic test and as a predictor of drug response in patients with ARVC. Studies of the pathoanatomic and pathophysiological substrates of reduced 123I-MIBG uptake may provide further information on the mechanisms of ventricular tachycardia in ARVC. Furthermore, future investigations of the regulation of postsynaptic f3-adrenergic receptors by PET may allow further insights into the relation among myocardial denervation, hypersensitivity to catecholamines, and the occurrence of ventricular tachycardia in patients with ARVC.
